🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with tirzepatide and fatty liver? Page 5

Has anyone dealt with tirzepatide and fatty liver?

Dr.PeteFamMed Tue, Nov 18, 2025 at 6:29 PM 39 replies 1,964 viewsPage 5 of 8
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Nov 22, 2025 at 1:45 AM#21
jason_paloalto said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

39 14jennifer_SEA, tyler_CSCS, VanRx_Mike and 36 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Nov 23, 2025 at 1:24 AM#22
jason_paloalto said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

38 13RunnerRach, TrialNerd_Beth, HPLC_Greg and 35 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Nov 24, 2025 at 1:03 AM#23
jason_paloalto said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

This answered a question I did not know how to ask. I will report back once I have actually tried it.

37 12LabKate, kate.chem, DataDave and 34 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Nov 25, 2025 at 12:43 AM#24

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

36 11DoseLogDan, SleepFixSam, PurityPaulOR and 33 others
Reply Quote Save Share Report
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Nov 26, 2025 at 12:23 AM#25
TrialNerd_Beth said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Same experience, arrived at from the opposite direction.

35 10PeptideChemSF, A1cHero_PHX, Dr.RenalNash and 32 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register